Ramamoorthy, P <br/><br/>
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.  [electronic resource] 

 -  International journal of oncology  Jan 2001 
 - 25-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Standard No.: </label>10.3892/ijo.18.1.25  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Arginine--genetics<br/>Breast Neoplasms--drug therapy<br/>Caspase 3<br/>Caspases--metabolism<br/>Cell Division--drug effects<br/>Cisplatin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme Activation<br/>Female<br/>Glycine--genetics<br/>Humans<br/>Point Mutation<br/>Prolactin--antagonists & inhibitors<br/>Transforming Growth Factor alpha--metabolism<br/>Transforming Growth Factor beta--metabolism<br/>Transforming Growth Factor beta1<br/>Tumor Cells, Cultured